Google News – FDA (biotech/pharma) External News
Life Sciences & Pharma Articles
Google News – FDA (biotech/pharma) External News
Oncolytics Biotech® Reports FDA Regulatory Milestone and - GlobeNewswire
Google News – FDA (biotech/pharma) External News
FDA takes first step toward ‘de facto’ ad ban: What to know - PRWeek
Google News – FDA (biotech/pharma) External News
FDA proposal to modernize drug manufacturing registration - The Pharma Letter
Google News – FDA (biotech/pharma) External News
Tris Pharma’s CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trial - Endpoints News
Google News – FDA (biotech/pharma) External News
Elevar liver cancer combo receives third FDA rejection - The Pharma Letter
Google News – Digital Health External News
Telemedicine's identity crisis reshapes digital care strategy - Healthcare IT News
Google News – Medical Devices External News
Three Decades of Food and Drug Administration Authorizations of Artificial Intelligence/Machine Learning-Enabled Medical Devices: Persistent Specialty Concentration and the Care-Delivery Gap (1995–2025) - Cureus
Google News – Medical Devices External News
Pharmaceutical venture announces $500M expansion in Northwest Austin - Community Impact
Google News – Clinical Trials External News
Design, simulate, refine: simulation-guided clinical trials for accelerated drug development - Nature
Google News – Clinical Trials External News
“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule - Clinical Trials Arena
Google News – Clinical Trials External News
GSK’s partner Hansoh Pharma succeeds in Chinese Phase III SCLC ADC trial - Clinical Trials Arena
Google News – Clinical Trials External News
Ibuprofen safely dampens inflammatory markers in 28-patient drug-resistant tuberculosis trial - Medical Xpress
Google News – Clinical Trials External News
FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab - Pharmaceutical Executive
Google News – Clinical Trials External News